Contrast media toxicity in children

Pediatric Radiology

Volumn 38, Issue SUPPL. 2, 2008, Pages

  Brasch, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contrast media toxicity; Contrast enhanced studies; Pediatric population

Indexed keywords

ACETYLCYSTEINE; ADRENALIN; AMINOPHYLLINE; BICARBONATE; CIMETIDINE; CONTRAST MEDIUM; CORTICOSTEROID; CREATININE; DIPHENHYDRAMINE; GADOLINIUM CHELATE; GLYCERYL TRINITRATE; IODINATED CONTRAST MEDIUM; MEPREDNISONE; METHYLPREDNISOLONE; NONIONIC CONTRAST MEDIUM; ORCIPRENALINE; PHENTOLAMINE; PREDNISONE; RANITIDINE; SALBUTAMOL; TERBUTALINE; TERBUTALINE SULFATE;

BRADYCARDIA; BRONCHOSPASM; COLLAPSE; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DRUG EFFECT; FACE EDEMA; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY DISEASE; KIDNEY FIBROSIS; LARYNX EDEMA; PREMEDICATION; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; UNCONSCIOUSNESS; URTICARIA;

CHEMOPREVENTION; CHILD; CONTRAST MEDIA; DRUG HYPERSENSITIVITY; FIBROSIS; HUMANS; KIDNEY DISEASES;

EID: 42049096180     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-008-0773-5     Document Type: Review

References (22)

1. Davidson CJ, Hlatky M, Morris KG et al (1989) Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 110:119-124
2. Schwab SJ, Hlatky MA, Pieper KS et al (1989) Contrast nephrotoxicity: a radomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320:149-153
3. Barrett BJ, Parfrey PS, Vavasour HM et al (1992) Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 41:1274-1279
4. Tippins RB, Torres WE, Baumgartner BR, Deborah A (2000) Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology 216:481-484
5. Manual on Contrast Media, Edition 4.1, 1998 (revised 2001). American College of Radiology
6. Kintzel PE (2001) Anticancer drug-induced kidney disorders. Drug Safety 24:19-38
7. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184
8. Shyu KG, Cheng JJ, Kuan P (2002) Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 40:1383-1388
9. Solomon R, Werner C, Mann D et al (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420
10. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291:2328-2334
11. Manual on Contrast Media, Edition 5.0 (2004). American College of Radiology
12. Guidelines for the Management of Reactions to Intravenous Contrast Media. Royal College of Radiologists, London
13. Chapters 1-6, in: Bush WH, Krecke KN, King BF, Bettmann MA (1999) Radiology Life Support (Rad-LS): A Practical Approach. London/Arnold Publishers, New York/Oxford University Press, pp. 1-99
14. Siegle RL, Halvorsen RA, Dillon J et al (1991) The use of iohexol in patients with previous reactions to ionic contrast material. A multicenter clinical trial. Inv Radiol 26:411-416
15. Dawson P, Sidhu PS (1993) Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents? Clin Radiol 48:225-226
16. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K (1990) Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175:621-628
17. Lasser EC, Berry CC, Mishkin MM et al (1994) Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media. Am J Roentgenol 162:523-526
18. Deo A, Fogel M, Cowper SE (2007) Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2(2):264-267 Mar
19. Morcos SK (2007) Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? Br J Radiol 80(950):73-76 Feb
20. Thomsen HS, Marckmann P, Logager VB (2007) Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis? Acta Radiol 48(6):593-596 Jul
21. Todd DJ, Kagan A, Chibnik LB, Kay J (2007) Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure. Arthritis Rheum 56(10):3433-3441 Oct
22. Wahba IM, Simpson EL, White K (2007) Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature. Am J Transplant 7(10):2425-2432 Oct